Light-adjustable IOLs provide stable outcomes

Article

Light-adjustable intraocular lenses (IOLs) provide near-emmetropic refractive outcomes and good uncorrected distance visual acuity that remains stable over time, according to a recent study.

Light-adjustable intraocular lenses (IOLs) provide near-emmetropic refractive outcomes and good uncorrected distance visual acuity that remains stable over time, according to a study published in the Journal of Cataract and Refractive Surgery.

Researchers at University Hospital Virgen de la Arrixaca, Murcia, Spain, performed a prospective non-randomized clinical trial of 53 eyes in 49 patients that had been implanted with a light-adjustable IOL. The researchers used spatial intensity profiles to correct refractive errors in the eyes, and estimated the effective changes in the IOLs' refraction after every treatment by subtracting those in the whole eye and the cornea.

After every light treatment and at 3-, 6- and 12-months, the researchers measured the refractive changes in the whole eye, refractive changes in the IOL, manifest refraction and visual acuity.

A maximum change in spherical power of the light-adjustable IOL of between −1.98 D and +2.30 D was induced by the combination of 2 light adjustments. In astigmatism the maximum change was up to −2.68 D. Axis errors were below 9 degrees. A small myopic shift of +0.01 to +0.57 D was produced by the 2 'lock-in' procedures.

To read an abstract of the study, click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
© 2025 MJH Life Sciences

All rights reserved.